Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan


Fauci set to be grilled by House GOP majority for first time

Dr. Anthony Fauci is facing the House GOP majority for the first time in a marathon two-day session behind closed doors to discuss the U.S. government’s handling of COVID-19.

Fauci, the former longtime director of the National Institute of Allergy and Infectious Diseases, will be interviewed by the House Oversight Committee’s select subcommittee on the coronavirus pandemic.

It’s taking place across two days on Jan. 8 and 9, with each day set to last seven hours without accounting for breaks, the committee announced on Thursday.

Fauci also agreed to testify in a public hearing at a later date, the committee said.

The immunologist was the most public-facing federal health official during the COVID-19 pandemic, under both the Trump and Biden administrations. President Biden ended up elevating Fauci to his top medical adviser, a position he left when he left his other role at the end of 2022.

He ended up taking a large share of blame for the negative impact of public health measures at the time, with his endorsement of lockdowns and school closures since being blamed for significant learning loss among students across the U.S.

Chairman Brad Wenstrup, R-Ohio, said Fauci’s testimony was critical to his panel’s investigation of the ‘origin of COVID-19, coercive mandates, gain-of-function type research, scientific censorship, and more.’

‘It is time for Dr. Fauci to confront the facts and address the numerous controversies that have arisen during and after the pandemic,’ Wenstrup said in a statement. ‘Americans deserve trusted public health leaders who prioritize the well-being of our people over any personal or political goals.’

‘Thankfully, retirement from public service does not shield one from congressional oversight nor accountability to the American people. During Dr. Fauci’s upcoming testimonies, honesty is non-negotiable,’ he added.

Wenstrup and Oversight Committee Chair James Comer, R-Ky., began probing Fauci and the Biden administration in February, sending letters to Fauci and Director of National Intelligence Avril Haines seeking information related to the theory that COVID-19 originated in a lab in Wuhan, China.

This post appeared first on FOX NEWS
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Editor's Pick

    Overview The world of business technology has evolved. Driven by the shift towards distributed work and cloud application delivery, enterprise infrastructure is undergoing a...

    Latest News

    Donald Trump’s defense attorneys Wednesday asked the federal judge handling the government’s classified documents case to allow the former president and his legal team...


    Bitcoin Rebounds to $69,000 Quick Look Bitcoin rebounds to $69,000, influenced by optimistic FR statements and anticipation of the halving event. FR officials’ comments...


    0xDistro ICO (DISTRO) is Live. What does it offer? In the world of decentralized finance, 0xDistro emerges as a promising project. It presented itself...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024